Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Adult
Biopsy
Cardiomyopathies
/ diagnostic imaging
Fluorodeoxyglucose F18
Gadolinium
Humans
Magnetic Resonance Imaging
/ methods
Male
Multimodal Imaging
/ methods
Positron-Emission Tomography
/ methods
Prognosis
Radiography, Thoracic
Radiopharmaceuticals
Sarcoidosis
/ diagnostic imaging
Sensitivity and Specificity
Diagnostic and prognostic application
MRI
PET
Sarcoid heart disease
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
12
10
2019
revised:
31
10
2019
pubmed:
28
11
2019
medline:
21
12
2021
entrez:
28
11
2019
Statut:
ppublish
Résumé
We present a case of a 42-year-old Japanese man with ocular and pulmonary sarcoidosis who eventually led to a diagnosis with cardiac sarcoidosis (CS) through endomyocardial biopsy (EMB), despite negative findings on both late gadolinium enhancement with cardiac magnetic resonance (LGE-CMR) imaging and
Identifiants
pubmed: 31773564
doi: 10.1007/s12350-019-01968-6
pii: 10.1007/s12350-019-01968-6
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Gadolinium
AU0V1LM3JT
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2149-2153Références
Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
doi: 10.1161/01.CIR.58.6.1204
Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2015;16:949-58.
doi: 10.1093/ehjci/jeu279
Guideline for Diagnosis and Treatment of Cardiac Sarcoidosis (JCS 2016). 2017;1-75. http://www.j-circ.or.jp/guideline/pdf/JCS2016_terasaki_h.pdf . Accessed Dec 2018
Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Nielsen JC, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1304-23.
doi: 10.1016/j.hrthm.2014.03.043
Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac sarcoidosis. J Am Coll Cardiol 2016;68:411-21.
doi: 10.1016/j.jacc.2016.03.605
Vöhringer M, Mahrholdt H, Yilmaz A, Sechtem U. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR). Herz 2007;32:129-37.
doi: 10.1007/s00059-007-2972-5
Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003;44:1030-6.
pubmed: 12843216
Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, Gulenchyn KY, Dekemp RA, Dasilva J, Birnie D, Wells GA, Beanlands RSB. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012;53:241-8.
doi: 10.2967/jnumed.111.090662
Sharp MB, Soufer A, Abdelmessih M, Rosenfeld LE, Baldassarre LA, Miller EJ. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis. J Nucl Cardiolol 2019. https://doi.org/10.1007/s12350-019-01640-z .
doi: 10.1007/s12350-019-01640-z
Aikawa T, Koyanagawa K, Oyama-Manabe N, Anzai T. Cardiac sarcoidosis mimicking myocardial infarction: A comprehensive evaluation using computed tomography and positron emission tomography. J Nucl Cardiolol 2019. https://doi.org/10.1007/s12350-019-01692-1 .
doi: 10.1007/s12350-019-01692-1
Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging 2018;11:94-107.
doi: 10.1016/j.jcmg.2017.02.021
Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2018;19:757-67.
doi: 10.1093/ehjci/jex340
Kim SJ, Pak K, Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-018-01582-y .
doi: 10.1007/s12350-018-01582-y
pubmed: 31768901
Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivistö SM, Kupari M. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011;270:461-8.
doi: 10.1111/j.1365-2796.2011.02396.x
Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietilä-Effati P, Utrianen S, Kupari M. Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015;131:624-32.
doi: 10.1161/CIRCULATIONAHA.114.011522